SCHEMBL3487253

SCHEMBL3487253

Cc1ccc(F)c(Oc2ccc(N)c(N(C)C(=O)O)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.38
GCK P35557 1/20 0.38
BACE1 P56817 2/20 0.37
SCN9A Q15858 2/20 0.34
PLG P00747 2/20 0.34
PLAU P00749 2/20 0.34
PLAT P00750 2/20 0.34
KDR P35968 2/20 0.34
HSD17B1 P14061 2/20 0.33
HSD17B2 P37059 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PIN1 Q13526 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3487238 0.90 PPARG (0.38) PPARGGCKBACE1PLAUSLC6A2
SCHEMBL3487538 0.89 GCK (0.39) PPARGGCKBACE1SLC6A4
SCHEMBL3487995 0.88 ALDH1A1 (0.40) GCKALDH1A1GAAMAPT
SCHEMBL27782479 0.85 GCK (0.35) PPARGGCKBACE1SCN9AKDR
SCHEMBL3487661 0.85 PARP10 (0.48) GCK
SCHEMBL3487567 0.84 CHEK2 (0.39) PPARGGCKHSD17B1HSD17B2SLC6A4
SCHEMBL3488808 0.83 SOS1 (0.42) PPARGSCN9ASLC6A4
SCHEMBL3488177 0.83 HSD17B1 (0.44) HSD17B1HSD17B2ALDH1A1MAPTSMN1; SMN2
SCHEMBL3487248 0.81 CARM1 (0.40) PPARGSLC6A2SLC6A4SLC6A3
SCHEMBL3487143 0.81 L3MBTL1 (0.42) PPARGALDH1A1GAAL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2138484-B1 FUSED BICYCLIC HETEROARYL DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2015-08-26 EP disclosed
US-20100048564-A1 FUSED BICYCLIC HETEROARYL DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-02-25 US disclosed
EP-2138484-A1 FUSED BICYCLIC HETEROARYL DERIVATIVES Daiichi Sankyo Company, Limited (JP) 2009-12-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048564-A1 FUSED BICYCLIC HETEROARYL DERIVATIVE PPARG, GPR119, PPARA PPARG 1/4885GCK 150/4885BACE1 2148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.